We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Unpublished Clinical Trial Data of MS Drug Alemtuzumab Concerning

News   Jun 16, 2017 | Original Story from Queen Mary's University London

 
Previously Unpublished Clinical Trial Data Explain Effects and Issues of Key MS Drug
 
 
 

RELATED ARTICLES

Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-Place

News

Technologies are reducing costs and changing the ways in which researchers and clinicians process and use therapeutic cells. Two new review articles detail the status of cell bioreactors in both stem cell and tissue/organ engineering applications.

READ MORE

Gene Regulator May Contribute to Protein Pileup in Exfoliation Glaucoma

News

Researchers are seeking factors that contribute to protein pileup in exfoliation glaucoma

READ MORE

What Makes Good Brain Proteins Turn Bad?

News

The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE